AbbVie

Kevin O'Sullivan will step down at the end of the year as president and CEO of Massachusetts Biomedical Initiatives after two decades at the Worcester agency.

AbbVie, a biopharmeceutical company with a major presence in Worcester, is contributing $500 million to continue an anti-aging initiative with a subsidiary of Google parent Alphabet.

The Worcester Business Development Corp. is seeking to demolish a long-vacant part of the former Worcester State Hospital now that a Chinese biomanufacturer has signed an agreement to locate there.

The Massachusetts Biotechnology Council, a nonprofit formed three decades ago to support the state's life sciences industry, is aiming to make it easier for communities to make themselves ready through the right zoning and permitting programs.

Framingham State University will start a new master in business administration degree program next fall, including a concentration on biotechnology.

LakePharma, a biologics company with a laboratory in Worcester, has raised $30 million to open additional locations in Massachusetts and its home state of California.

By all accounts, Worcester city officials appear to want to give the Pawtucket Red Sox a big chunk of money to lure them to the Canal District.

The Worcester Business Development Corp. and the state signed a land disposition agreement Thursday for a planned 44-acre biomanufacturing campus near the UMass Medical School.

The California biologics company expected to be the first tenant is no longer lined up for redevelopment of the former Worcester State Hospital, and the land sale from the state to the Worcester Business Develolpment Corp. is behind schedule.

In the last five years, 75% of Worcester tax breaks were successful, but the city kept the benefits even for almost all missing their goals.